Cargando…

Microphthalmia-Associated Transcription Factor (MITF) Regulates Immune Cell Migration into Melanoma

Microphthalmia-associated transcription factor (MITF) is a key transcription factor in melanoma development and progression. MITF amplification and downregulation have been observed in a significant proportion of melanoma patients and correlate with clinical outcomes. Here, we have investigated the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wiedemann, Gabriela M, Aithal, Celina, Kraechan, Angelina, Heise, Constanze, Cadilha, Bruno L, Zhang, Jin, Duewell, Peter, Ballotti, Robert, Endres, Stefan, Bertolotto, Corine, Kobold, Sebastian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Neoplasia Press 2018
Materias:	Original article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6290759/ https://www.ncbi.nlm.nih.gov/pubmed/30502589 http://dx.doi.org/10.1016/j.tranon.2018.10.014

Ejemplares similares

Hypoxia-inducible factor 1α is a new target of microphthalmia-associated transcription factor (MITF) in melanoma cells
por: Buscà, Roser, et al.
Publicado: (2005)

The complex relationship between MITF and the immune system: a Melanoma ImmunoTherapy (response) Factor?
por: Ballotti, Robert, et al.
Publicado: (2020)

PD1-CD28 Fusion Protein Enables CD4+ T Cell Help for Adoptive T Cell Therapy in Models of Pancreatic Cancer and Non-hodgkin Lymphoma
por: Rataj, Felicitas, et al.
Publicado: (2018)

Microphthalmia Gene Product as a Signal Transducer in cAMP-Induced Differentiation of Melanocytes
por: Bertolotto, Corine, et al.
Publicado: (1998)

FANCD2 functions as a critical factor downstream of MiTF to maintain the proliferation and survival of melanoma cells
por: Bourseguin, Julie, et al.
Publicado: (2016)

High-affinity CD16-polymorphism and Fc-engineered antibodies enable activity of CD16-chimeric antigen receptor-modified T cells for cancer therapy
por: Rataj, Felicitas, et al.
Publicado: (2018)

The “ART” of Epigenetics in Melanoma: From histone “Alterations, to Resistance and Therapies”
por: Strub, Thomas, et al.
Publicado: (2020)

Mutation of microphthalmia-associated transcription factor (mitf) in zebrafish sensitizes for glomerulopathy
por: Müller-Deile, Janina, et al.
Publicado: (2019)

Inhibition of NAT10 Suppresses Melanogenesis and Melanoma Growth by Attenuating Microphthalmia-Associated Transcription Factor (MITF) Expression
por: Oh, Taek-In, et al.
Publicado: (2017)

Mitf-Mdel, a novel melanocyte/melanoma-specific isoform of microphthalmia-associated transcription factor-M, as a candidate biomarker for melanoma
por: Wang, Yixiang, et al.
Publicado: (2010)

MITF activity is regulated by a direct interaction with RAF proteins in melanoma cells
por: Estrada, Charlène, et al.
Publicado: (2022)

Negative Regulatory Loop between Microphthalmia-Associated Transcription Factor (MITF) and Notch Signaling
por: Golan, Tamar, et al.
Publicado: (2019)

Photoreceptor degeneration in microphthalmia (Mitf) mice: partial rescue by pigment epithelium-derived factor
por: Chen, Yu, et al.
Publicado: (2019)

The microphthalmia-associated transcription factor (Mitf) gene and its role in regulating eye function
por: García-Llorca, Andrea, et al.
Publicado: (2019)

The underestimated role of the microphthalmia-associated transcription factor (MiTF) in normal and pathological haematopoiesis
por: Oppezzo, Alessia, et al.
Publicado: (2021)

Mouse microphthalmia‐associated transcription factor (Mitf) mutations affect the structure of the retinal vasculature
por: Daníelsson, Stefán Broddi, et al.
Publicado: (2022)

Focus on cutaneous and uveal melanoma specificities
por: Pandiani, Charlotte, et al.
Publicado: (2017)

microRNA-155, Induced by Interleukin-1ß, Represses the Expression of Microphthalmia-Associated Transcription Factor (MITF-M) in Melanoma Cells
por: Arts, Nathalie, et al.
Publicado: (2015)

Lysine Methyltransferase NSD1 and Cancers: Any Role in Melanoma?
por: Krossa, Imène, et al.
Publicado: (2022)

Characterizing the Coding Region Determinant-Binding Protein (CRD-BP)-Microphthalmia-associated Transcription Factor (MITF) mRNA interaction
por: van Rensburg, Gerrit, et al.
Publicado: (2017)

Gene Expression Profiling Identifies Microphthalmia-Associated Transcription Factor (MITF) and Dickkopf-1 (DKK1) as Regulators of Microenvironment-Driven Alterations in Melanoma Phenotype
por: Hartman, Mariusz L., et al.
Publicado: (2014)

An Update on the Role of Ubiquitination in Melanoma Development and Therapies
por: Soysouvanh, Frédéric, et al.
Publicado: (2021)

Hair Dyes Resorcinol and Lawsone Reduce Production of Melanin in Melanoma Cells by Tyrosinase Activity Inhibition and Decreasing Tyrosinase and Microphthalmia-Associated Transcription Factor (MITF) Expression
por: Lee, Shu-Mei, et al.
Publicado: (2015)

The MITF regulatory network in melanoma
por: Chauhan, Jagat S., et al.
Publicado: (2022)

Regulatory and Functional Connection of Microphthalmia-Associated Transcription Factor and Anti-Metastatic Pigment Epithelium Derived Factor in Melanoma()
por: Fernández-Barral, Asunción, et al.
Publicado: (2014)

PD-1-CD28 fusion protein strengthens mesothelin-specific TRuC T cells in preclinical solid tumor models
por: Lesch, Stefanie, et al.
Publicado: (2022)

Limitations in the Design of Chimeric Antigen Receptors for Cancer Therapy
por: Stoiber, Stefan, et al.
Publicado: (2019)

Targeted activation of melanoma differentiation-associated protein 5 (MDA5) for immunotherapy of pancreatic carcinoma
por: Duewell, Peter, et al.
Publicado: (2015)

Hispolon Decreases Melanin Production and Induces Apoptosis in Melanoma Cells through the Downregulation of Tyrosinase and Microphthalmia-Associated Transcription Factor (MITF) Expressions and the Activation of Caspase-3, -8 and -9
por: Chen, Yi-Shyan, et al.
Publicado: (2014)

CD271 is an imperfect marker for melanoma initiating cells
por: Cheli, Yann, et al.
Publicado: (2014)

Killing Mechanisms of Chimeric Antigen Receptor (CAR) T Cells
por: Benmebarek, Mohamed-Reda, et al.
Publicado: (2019)

MITF and PAX3 Play Distinct Roles in Melanoma Cell Migration; Outline of a “Genetic Switch” Theory Involving MITF and PAX3 in Proliferative and Invasive Phenotypes of Melanoma
por: Eccles, Michael R., et al.
Publicado: (2013)

MITF and TFEB cross-regulation in melanoma cells
por: Ballesteros-Álvarez, Josué, et al.
Publicado: (2020)

Endolysosomal Cation Channels and MITF in Melanocytes and Melanoma
por: Abrahamian, Carla, et al.
Publicado: (2021)

SIRT1 promotes proliferation and inhibits the senescence-like phenotype in human melanoma cells
por: Ohanna, Mickaël, et al.
Publicado: (2014)

Melanoma: From Melanocyte to Genetic Alterations and Clinical Options
por: Bertolotto, Corine
Publicado: (2013)

Anophthalmia and microphthalmia
por: Verma, Amit S, et al.
Publicado: (2007)

Immune Checkpoints in Cancers: From Signaling to the Clinic
por: Pisibon, Céline, et al.
Publicado: (2021)

The macrophage migration inhibitory factor (MIF)-homologue D-dopachrome tautomerase is a therapeutic target in a murine melanoma model
por: Kobold, Sebastian, et al.
Publicado: (2013)

A Conditional Zebrafish MITF Mutation Reveals MITF Levels Are Critical for Melanoma Promotion vs. Regression In Vivo
por: Lister, James A, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_9jp4r5erdfgtumq5j3348slusk